Compounded "semaglutide" is not FDA approved semaglutide.com Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law As unregulated peptides grow in popularity, doctors warn of unknown risks ABC7 San Francisco The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA moves toward easing restrictions on certain peptides BioPharma Dive BPC 157: Miracle Healing Peptide or Hidden Danger?